FI951798A - Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina - Google Patents
Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina Download PDFInfo
- Publication number
- FI951798A FI951798A FI951798A FI951798A FI951798A FI 951798 A FI951798 A FI 951798A FI 951798 A FI951798 A FI 951798A FI 951798 A FI951798 A FI 951798A FI 951798 A FI951798 A FI 951798A
- Authority
- FI
- Finland
- Prior art keywords
- receptor antagonists
- benzofuran derivatives
- benzofuran
- derivatives
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929221761A GB9221761D0 (en) | 1992-10-16 | 1992-10-16 | Chemical compounds |
| PCT/EP1993/002833 WO1994008993A1 (en) | 1992-10-16 | 1993-10-14 | Benzofuran derivatives as 5-ht1-like receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI951798A0 FI951798A0 (fi) | 1995-04-13 |
| FI951798A true FI951798A (fi) | 1995-04-13 |
Family
ID=10723562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951798A FI951798A (fi) | 1992-10-16 | 1995-04-13 | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5494910A (fi) |
| EP (1) | EP0664804A1 (fi) |
| JP (1) | JPH06211842A (fi) |
| KR (1) | KR940009179A (fi) |
| CN (1) | CN1092420A (fi) |
| AP (1) | AP425A (fi) |
| AU (1) | AU5333794A (fi) |
| CA (1) | CA2146569A1 (fi) |
| CZ (1) | CZ96895A3 (fi) |
| EC (1) | ECSP941050A (fi) |
| FI (1) | FI951798A (fi) |
| GB (1) | GB9221761D0 (fi) |
| HU (1) | HUT72752A (fi) |
| IL (1) | IL107302A0 (fi) |
| IS (1) | IS4081A (fi) |
| MX (1) | MX9306394A (fi) |
| NO (1) | NO951433L (fi) |
| PE (1) | PE51294A1 (fi) |
| PL (1) | PL308357A1 (fi) |
| RU (1) | RU95110110A (fi) |
| SI (1) | SI9300542A (fi) |
| TW (1) | TW262473B (fi) |
| WO (1) | WO1994008993A1 (fi) |
| ZA (1) | ZA937633B (fi) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407447D0 (en) * | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
| JPH10501212A (ja) * | 1994-05-19 | 1998-02-03 | メルク シヤープ エンド ドーム リミテツド | ５−ｈｔ▲下１ｄ▼−アルファ作働薬としてのインドール−３−イルアルキルのピペラジン、ピペリジンおよびテトラヒドロピリジン誘導体 |
| GB9610979D0 (en) * | 1996-05-24 | 1996-07-31 | Merck Sharp & Dohme | Therapeutic agents |
| US5792763A (en) * | 1996-10-08 | 1998-08-11 | Eli Lilly And Company | Serotonin 5-HT1F agonists |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US20030017175A1 (en) * | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| US20030198669A1 (en) * | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
| EP2734634B1 (en) | 2011-07-22 | 2019-08-21 | The University of Chicago | Igf-1 for use in the treatment of migraine |
| KR101443041B1 (ko) * | 2013-05-06 | 2014-09-23 | (주)하이레벤 | 태양광 발전설비의 효율향상설비 |
| IL310378A (en) | 2021-08-12 | 2024-03-01 | Kuleon Llc | Serotonin receptor agonists that cause hallucinations and that do not cause hallucinations and methods for their preparation and use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670105A1 (de) * | 1966-07-08 | 1970-12-10 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
-
1992
- 1992-10-16 GB GB929221761A patent/GB9221761D0/en active Pending
-
1993
- 1993-10-11 IS IS4081A patent/IS4081A/is unknown
- 1993-10-14 US US08/406,981 patent/US5494910A/en not_active Expired - Fee Related
- 1993-10-14 MX MX9306394A patent/MX9306394A/es unknown
- 1993-10-14 RU RU95110110/04A patent/RU95110110A/ru unknown
- 1993-10-14 AU AU53337/94A patent/AU5333794A/en not_active Abandoned
- 1993-10-14 EP EP93923463A patent/EP0664804A1/en not_active Withdrawn
- 1993-10-14 KR KR1019930021263A patent/KR940009179A/ko not_active Application Discontinuation
- 1993-10-14 CA CA002146569A patent/CA2146569A1/en not_active Abandoned
- 1993-10-14 WO PCT/EP1993/002833 patent/WO1994008993A1/en not_active Application Discontinuation
- 1993-10-14 ZA ZA937633A patent/ZA937633B/xx unknown
- 1993-10-14 CZ CZ95968A patent/CZ96895A3/cs unknown
- 1993-10-14 HU HU9501073A patent/HUT72752A/hu unknown
- 1993-10-14 PL PL93308357A patent/PL308357A1/xx unknown
- 1993-10-15 IL IL107302A patent/IL107302A0/xx unknown
- 1993-10-15 CN CN93115016A patent/CN1092420A/zh active Pending
- 1993-10-15 AP APAP/P/1993/000581A patent/AP425A/en active
- 1993-10-15 JP JP5258631A patent/JPH06211842A/ja active Pending
- 1993-10-15 SI SI9300542A patent/SI9300542A/sl unknown
- 1993-11-04 TW TW082108174A patent/TW262473B/zh active
-
1994
- 1994-03-02 EC EC1994001050A patent/ECSP941050A/es unknown
- 1994-04-13 PE PE1994240029A patent/PE51294A1/es not_active Application Discontinuation
-
1995
- 1995-04-12 NO NO951433A patent/NO951433L/no unknown
- 1995-04-13 FI FI951798A patent/FI951798A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994008993A1 (en) | 1994-04-28 |
| NO951433D0 (no) | 1995-04-12 |
| AU5333794A (en) | 1994-05-09 |
| HU9501073D0 (en) | 1995-06-28 |
| CZ96895A3 (en) | 1995-12-13 |
| CN1092420A (zh) | 1994-09-21 |
| SI9300542A (en) | 1994-06-30 |
| MX9306394A (es) | 1994-05-31 |
| US5494910A (en) | 1996-02-27 |
| AP425A (en) | 1995-11-08 |
| PL308357A1 (en) | 1995-07-24 |
| KR940009179A (ko) | 1994-05-20 |
| IL107302A0 (en) | 1994-01-25 |
| IS4081A (is) | 1994-04-17 |
| JPH06211842A (ja) | 1994-08-02 |
| ECSP941050A (es) | 1994-11-16 |
| EP0664804A1 (en) | 1995-08-02 |
| RU95110110A (ru) | 1996-12-27 |
| PE51294A1 (es) | 1995-01-06 |
| GB9221761D0 (en) | 1992-12-02 |
| FI951798A0 (fi) | 1995-04-13 |
| ZA937633B (en) | 1994-08-01 |
| AP9300581A0 (en) | 1993-10-31 |
| NO951433L (no) | 1995-04-12 |
| TW262473B (fi) | 1995-11-11 |
| HUT72752A (en) | 1996-05-28 |
| CA2146569A1 (en) | 1994-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE226578T1 (de) | Benzofuranderivate als tachykininantagonisten | |
| DE69207351D1 (de) | Fibrinogen-Rezeptor-Antagoniste | |
| DE69127791D1 (de) | Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten | |
| DE69325167D1 (de) | Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten | |
| DE69232003D1 (de) | Benzanilidderivate als 5-HT1D-Antagonisten | |
| NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
| MX9101311A (es) | Antagonistas receptores de fibrinogeno | |
| DE69327720D1 (de) | Endothelin rezeptor antagonisten | |
| DE69605430D1 (de) | Chinolin-2-on derivate als serotonin antagonisten | |
| ID16742A (id) | Antagonis reseptor endotelin | |
| MX9100717A (es) | Antagonistas de la bradiquinina | |
| FI961628A (fi) | Indolijohdannaisia NMDA-antagonisteina | |
| DE69418045D1 (de) | Amidderivate als 5ht1d rezeptor antagonisten | |
| KR950703530A (ko) | 5-HT4 길항제(5-HT4 Antagonists) | |
| TR26336A (tr) | SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI | |
| FI951798A (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
| ATE116980T1 (de) | Verbesserungen an leukotrien-antagonieten. | |
| DE69703242D1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten | |
| NO179550C (no) | Tachykinin reseptorantagonister | |
| DE69717449D1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten | |
| ATE208764T1 (de) | Isazole derivate als fibrinogen-rezeptor- antagonisten | |
| NO924745D0 (no) | Benzofuraner | |
| FI940607A0 (fi) | Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina | |
| NO921942D0 (no) | Benzofuranderivater | |
| KR950700297A (ko) | 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist) |